2006•Leukemia ResearchRequires access

Long-term remission in BCR/ABL-positive AML-M6 patient treated with Imatinib Mesylate

Franca Pompetti, Antonio Spadano, Antonella Sau, Antonio Mennucci, Rosa Russo, Virginia Catinella, Paolo Guanciali Franchi, Giuseppe Calabrese, Giandomenico Palka, Giuseppe Fioritoni, Antonio Iacone

Open publisher page 19 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 19 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Imatinib mesylate, Myeloid leukemia, Medicine, Imatinib, Internal medicine, Chemotherapy, Oncology, breakpoint cluster region

Back to paper search Browse research topics Original source

Long-term remission in BCR/ABL-positive AML-M6 patient treated with Imatinib Mesylate — Research Paper | ScholarLens